Skip to main content
Register
Mobile App
Schedule
Full Schedule
Browse By Date
ON DEMAND
Friday, October 20, 2023
Saturday, October 21, 2023
Sunday, October 22, 2023
Monday, October 23, 2023
Tuesday, October 24, 2023
Wednesday, October 25, 2023
Thursday, October 26, 2023
Browse By Track
Browse by Session Type
Browse By Speaker
Career Development
Poster Abstracts
Browse by Title
Browse by Date
Browse by Author
Browse By Track
Sponsors and Exhibitors
Floor Plan
Browse by Company
Browse by Booths
Awards
Social Media Toolkit
My Experience
Login Required
Attendee List
Login Required
Orlando Info and Discounts
Login Required
Toggle navigation
Login
Search
Home
Register
Mobile App
+
Schedule
Full Schedule
+
Browse By Date
ON DEMAND
Friday, October 20, 2023
Saturday, October 21, 2023
Sunday, October 22, 2023
Monday, October 23, 2023
Tuesday, October 24, 2023
Wednesday, October 25, 2023
Thursday, October 26, 2023
Browse By Track
Browse by Session Type
Browse By Speaker
Career Development
+
Poster Abstracts
Browse by Title
Browse by Date
Browse by Author
Browse By Track
+
Sponsors and Exhibitors
Floor Plan
Browse by Company
Browse by Booths
Awards
Social Media Toolkit
My Experience
Login Required
Attendee List
Login Required
Orlando Info and Discounts
Login Required
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Schedule
Home
Poster Schedule
All Days
Mon, Oct 23
Tue, Oct 24
Wed, Oct 25
Poster Schedule
417 results found
Type here to filter the list
Tuesday, October 24, 2023
9:30 AM – 10:30 AM
ET
(T0930-01-01) Solid-State Properties and Phase Behaviors of Ephedrine Cyclamate
Favorite
9:30 AM – 10:30 AM
ET
(T0930-01-03) Nanostructured Lipid Carriers for Improved Ocular Bioavailability of Poorly Water-Soluble Drugs
Favorite
9:30 AM – 10:30 AM
ET
(T0930-01-04) High Throughput Excipient Compatibility Screen Visualization and Analysis Using Spotfire
Favorite
9:30 AM – 10:30 AM
ET
(T0930-01-05) Acceptable Solid Oral Dosage Forms for Older Adults as Prerequisite for Medication Adherence – The Current Situation
Favorite
9:30 AM – 10:30 AM
ET
(T0930-01-06) Comparison of High Shear Granulation and Twin-Screw Granulation for Achieving High Drug Loading in Extrusion-Spheronization of a Highly Soluble API (Active Pharmaceutical Ingredient)
Favorite
9:30 AM – 10:30 AM
ET
(T0930-02-08) Accelerating Development of FDM 3D Printed Medicines with Machine Learning
Favorite
9:30 AM – 10:30 AM
ET
(T0930-02-09) Detailed In Vivo Evaluation of Novel Bioadhesive Microemulsion-Based Long-Acting Glaucoma Eye Drops
Favorite
9:30 AM – 10:30 AM
ET
(T0930-02-10) Engineered Anti-CD40 Agonist Antibody as a Novel Cancer Neoantigen Vaccines
Favorite
9:30 AM – 10:30 AM
ET
(T0930-02-11) Formulation and Process Variables that Affect Tableting of Carbamazepine Dihydrate
Favorite
9:30 AM – 10:30 AM
ET
(T0930-02-12) Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease
Favorite
9:30 AM – 10:30 AM
ET
(T0930-03-15) In Vivo Confirmation of the Permeation Enhancement Capacity of Labrafac™ MC60
Favorite
9:30 AM – 10:30 AM
ET
(T0930-03-16) Remote Loading of Setmelanotide in Poly(lactic-co-glycolic acid) Microspheres for Long-Term Obesity Control
Favorite
9:30 AM – 10:30 AM
ET
(T0930-03-17) Fabrication of Caffeine Transdermal Film Using the Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing
Favorite
9:30 AM – 10:30 AM
ET
(T0930-03-18) Development and Optimization of an In Vitro Release Assay for Evaluation of Liposomal Irinotecan Formulation
Favorite
9:30 AM – 10:30 AM
ET
(T0930-03-19) Temperature-Dependent Terahertz Time-Domain Spectroscopy as a Tool to Predict Crystallisation Tendencies of Amorphous Drugs
Favorite
9:30 AM – 10:30 AM
ET
(T0930-03-20) Impact of Tooling Size on the Heckel Profile and Derived Compressibility Parameters
Favorite
9:30 AM – 10:30 AM
ET
(T0930-03-21) Improving the Solubility and Absorption of the Low-Solubility Compound Aripiprazole by Electrospinning Nanofiber Formulation
Favorite
9:30 AM – 10:30 AM
ET
(T0930-04-22) A Complete Automation Solution Using an Acoustic Ejection Mass Spectrometry System for Rapid Sample Analysis
Favorite
9:30 AM – 10:30 AM
ET
(T0930-04-23) Impact of a Novel Thin Film Platform on the Uptake and Permeability of Virus-Based Vaccines in an In Vitro Model of the Human Oral Mucosa
Favorite
9:30 AM – 10:30 AM
ET
(T0930-04-24) Urea-Based Compound UR-1-1-13 Affects the Mitochondrial Health of Triple-Negative Breast Cancer Cells
Favorite
9:30 AM – 10:30 AM
ET
(T0930-04-25) ISMICAP: A Model for Delving into Blood-Brain Barrier Mysteries
Favorite
9:30 AM – 10:30 AM
ET
(T0930-04-26) A New Class of Lipids Conjugated to Poly(ethylene glycol) Structural Isomers: An Efficient Approach to Evade Immune Recognition of Lipid Nanoparticles
Favorite
9:30 AM – 10:30 AM
ET
(T0930-04-27) DNA Hydroxymethylation and TET Enzymes Changes Induced by the Curcumin Analog Dimethoxycurcumin
Favorite
9:30 AM – 10:30 AM
ET
(T0930-04-28) ABCB1 and HMGB1 Gene Polymorphism and Adverse Reactions to Carboplatin and Paclitaxel Treatment in Patients with Non-small Cell Lung Cancer
Favorite
9:30 AM – 10:30 AM
ET
(T0930-06-36) scRNA-seq - A Potential ELISpot Alternative?
Favorite
9:30 AM – 10:30 AM
ET
(T0930-06-37) Highly Sensitive Analysis Using EVOSEP-LC/MS Assay for Targeted PD-L1 and PD1 Expression Level for Predicting Response to Immune Checkpoint Inhibitors
Favorite
9:30 AM – 10:30 AM
ET
(T0930-06-38) Quantitative Analysis of GalNAc-siRNA Conjugates in Tissue Homogenate Using Two-Dimensional Liquid Chromatography Coupled with Tandem Mass Spectrometry
Favorite
9:30 AM – 10:30 AM
ET
(T0930-06-39) Quantitative Characterization of Oligonucleotide Transport Vehicle (OTV) In Vivo Distribution and Pharmacokinetics using Ultra-sensitive, Plate-Based Bioanalytical Methods
Favorite
9:30 AM – 10:30 AM
ET
(T0930-06-40) Optimizing Discovery Bioanalytical Strategy for Macrocyclic Peptides and Degraders with Orbitrap High Resolution Mass Spectrometry
Favorite
9:30 AM – 10:30 AM
ET
(T0930-09-56) Development of a High Purity, High Productivity Cell Culture Media Additive
Favorite
9:30 AM – 10:30 AM
ET
(T0930-09-57) In-Depth Characterization of PS-80 Degradation in Biologics Drug Products by Reversed Phase Liquid Chromatography Coupled with Charge-Reduction High Resolution Mass Spectrometry
Favorite
9:30 AM – 10:30 AM
ET
(T0930-09-58) Crystallization Kinetics of Amorphous Lactose: The Difference between α and β Anomers
Favorite
9:30 AM – 10:30 AM
ET
(T0930-09-59) Analysis of Semi- and Non-Volatile Leachables via an Enhanced HPLC-UV Method
Favorite
9:30 AM – 10:30 AM
ET
(T0930-09-60) Development, Optimization and Validation of UPLC Method for Determination of Flavonoids from Seed Extracts of Elite Pongamia pinnata
Favorite
9:30 AM – 10:30 AM
ET
(T0930-09-62) An Improved Spray Dried Dispersion Model: Integrating Machine Learning to Predict Optimized Process Parameters
Favorite
9:30 AM – 10:30 AM
ET
(T0930-10-63) Cognitive Impairment on the Physicochemical Characteristics of Fasting Gastric Contents of Individuals in Advanced Age: Initial Data
Favorite
9:30 AM – 10:30 AM
ET
(T0930-10-64) Pharmacokinetic Studies of 7-hydroxymitragynine, the Active Metabolite of Mitragynine, in Rats
Favorite
9:30 AM – 10:30 AM
ET
(T0930-10-65) Human Renal Clearance Prediction Using Monkey
Favorite
9:30 AM – 10:30 AM
ET
(T0930-10-66) Impact of Aging on Relative Gene Expression of Tight Junction Proteins in Duodenal and Colonic Epithelium: Preliminary Data
Favorite
9:30 AM – 10:30 AM
ET
(T0930-10-67) A Sensitive and Specific Human Primary Stem Cell-Based In Vitro Assay for Predicting Gastrointestinal Toxicity Risk
Favorite
9:30 AM – 10:30 AM
ET
(T0930-10-68) Investigating the Mechanism of Synergism of Pyrazinamide When Administered in Combination with Spectinamide 1599 in Murine TB Models
Favorite
9:30 AM – 10:30 AM
ET
(T0930-10-69) Optimizing Carvedilol Dosing Following Gastric Bypass Surgery Using Population-Based PK/PD Modeling
Favorite
9:30 AM – 10:30 AM
ET
(T0930-11-70) Amikacin Coated 3D-Printed Metal Devices for Prevention of Postsurgical Infections (PSIs)
Favorite
9:30 AM – 10:30 AM
ET
(T0930-11-71) Development of a Novel Tacrolimus Loaded Thermoresponsive Nanoemulgel for Local Immunomodulation in Organ Rejection
Favorite
9:30 AM – 10:30 AM
ET
(T0930-11-72) Enhanced Transdermal Delivery of Lurasidone for Potential Treatment of Schizophrenia
Favorite
9:30 AM – 10:30 AM
ET
(T0930-11-73) Implantable Albumin Gels for Biomimetic Delivery of Anticancer Drug for Breast Therapy
Favorite
9:30 AM – 10:30 AM
ET
(T0930-11-74) Microbicide-Containing SMART Gel for Female-Controlled Multipurpose Prevention
Favorite
9:30 AM – 10:30 AM
ET
(T0930-11-75) Role of PLGA Variability in Controlled Drug Release from Dexamethasone Intravitreal Implants
Favorite
9:30 AM – 10:30 AM
ET
(T0930-12-77) Bioinspired Nanoerythrocytes for Metabolic Microenvironment Remodeling and Long-Term Prognosis Promoting of Acute Ischemic Stroke
Favorite
9:30 AM – 10:30 AM
ET
(T0930-12-78) Preparation and Evaluation of Dexamethasone Phosphate-Encapsulated Liposomal Gel Formulation for Intratympanic Delivery
Favorite
9:30 AM – 10:30 AM
ET
(T0930-12-79) Transdermal Permeability Assay of LK 467, a Selective and Potent Agonist of the Melanocortin 1 Receptor, Demonstrating the Efficacy of Topical Application
Favorite
9:30 AM – 10:30 AM
ET
(T0930-12-80) Regulatory Challenges with Formulation Assessment of Parenteral Drug Products During ANDA Review: Case Studies and Considerations
Favorite
9:30 AM – 10:30 AM
ET
(T0930-12-81) Long-Acting Drug Delivery System for Subcutaneous, Intravitreal, and Intra-articular Administration using Hyaluronic Acid-Based In Situ Gelling Nanosuspension Formulation of Water-Insoluble Drugs
Favorite
9:30 AM – 10:30 AM
ET
(T0930-12-82) Dexamethasone-Loaded Colon-Targeting UniORV
®
with Improved Anti-inflammatory Effects and Reduced Risks of Systemic Side Effects
Favorite
9:30 AM – 10:30 AM
ET
(T0930-12-83) Co-micelle Technology by Hyaluronic Acid (HA) Nanogel (trade name Sonanos
TM
) Solubilize as much of a Poorly Water-Soluble Drug as Possible with as Little as Possible
Favorite
9:30 AM – 10:30 AM
ET
(T0930-02-14) Improvement of Mechanical Properties of MRTX0902 by Crystalline Form Selection and Particle Engineering
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-01) Nifuroxazide-Loaded Lipid Nanocarriers – An Effective Treatment against Lung Cancer
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-02) Enhancement of Permeation of an Anti-Glaucoma Medication Brinzolamide via OcuSurf™ Lipid Nanoparticles
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-03) Critical Material Attributes (CMA) of Excipients in Topical Formulations: The Pitfalls of Switching between Compendial Raw Materials without a Full Analysis of all Critical Quality Attributes (CQA)
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-05) Hydrophilic Polymers in Spray Dried Amorphous Dispersions - Exploring Polyvinyl Alcohol
Favorite
10:30 AM – 11:30 AM
ET
(T1030-02-08) Adjuvanted Ionizable Lipid Nanoparticles for mRNA Delivery
Favorite
10:30 AM – 11:30 AM
ET
(T1030-02-09) Development and Characterization of Highly Muco-penetrative PLGA Nanoparticles for theTreatment of Inflammation in Chronic Lung Disease
Favorite
10:30 AM – 11:30 AM
ET
(T1030-02-10) Enhancement of Optical Properties of Graphene Quantum Dots Using Nitrogen Doping: An Analytical Aspect
Favorite
10:30 AM – 11:30 AM
ET
(T1030-02-12) Nanoparticle in Rapidly Soluble Vaginal Film: A Promising Formulation for Pre-exposure Prophylaxis of HIV
Favorite
10:30 AM – 11:30 AM
ET
(T1030-03-15) Expanding the Space of Hydroxyl-Rich Lyoprotectants through High-Throughput Screening to Support the Lyophilization of Yeast-Based Therapeutics
Favorite
10:30 AM – 11:30 AM
ET
(T1030-03-17) Optimized and Scalable LNP Composition for RNA Vaccine Delivery
Favorite
10:30 AM – 11:30 AM
ET
(T1030-03-18) Solubility Measurement and Modeling of Bisacodyl in Mono Solvent and Binary Solvent Mixture, and Its Application for Pharmaceutical Industry
Favorite
10:30 AM – 11:30 AM
ET
(T1030-03-19) Influence of Key Formulation Factors in Oral Thin Film – Part 2 (Polyethylene Oxide)
Favorite
10:30 AM – 11:30 AM
ET
(T1030-03-20) Material Deformation or Material Hardness or Both: Tool for Predicting Tabletability Performance
Favorite
10:30 AM – 11:30 AM
ET
(T1030-03-21) Injection-Molded Coamorphous Tablets: Analysis of Intermolecular Interaction and Crystallization Propensity
Favorite
10:30 AM – 11:30 AM
ET
(T1030-04-22) Impact of Solvent Choice in the Spray-Freeze-Drying of Insoluble Excipients
Favorite
10:30 AM – 11:30 AM
ET
(T1030-04-24) A Simple and Facile Platform for Semi-Solid Extrusion of Different Formulations Containing a Drug-Loaded Mesoporous Material
Favorite
10:30 AM – 11:30 AM
ET
(T1030-04-26) Oral Cavity Permeability Assessment Using Sublingual and Buccal In Vitro Tissue Models
Favorite
10:30 AM – 11:30 AM
ET
(T1030-04-27) Identification of FDA-Approved Drugs Targeting Malonyl Co-A Decarboxylase for the Treatment of Obesity
Favorite
10:30 AM – 11:30 AM
ET
(T1030-04-28) Co-administration of Irinotecan with Naturally Occurring Flavonoids Exhibits Synergistic Antitumor Effects on Colon Xenograft Tumors
Favorite
10:30 AM – 11:30 AM
ET
(T1030-06-36) Sanger Sequencing of Oligonucleotide Pharmaceuticals
Favorite
10:30 AM – 11:30 AM
ET
(T1030-06-37) Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
Favorite
10:30 AM – 11:30 AM
ET
(T1030-06-38) Optimizing Flow Cytometric Immune Phenotyping and CAR Persistence Determination to Enable Immune Monitoring of Patients under CAR T Cell Therapy
Favorite
10:30 AM – 11:30 AM
ET
(T1030-06-39) Optimal Mobile Phase and Antisense Oligonucleotide Modifications for the Internal Standard in Bioanalysis of Therapeutic Oligonucleotides by Ion-Pair LC-MS/MS
Favorite
10:30 AM – 11:30 AM
ET
(T1030-06-40) Detection and Quantification of Gentamicin in the Inner Ear Using Different Liquid Chromatography Methods
Favorite
10:30 AM – 11:30 AM
ET
(T1030-08-49) Leveraging Automation to Develop a Robust High Throughput Thermodynamic Solubility Assay Using Neat Drug Powder
Favorite
10:30 AM – 11:30 AM
ET
(T1030-08-52) Characterization of Host Cell Protein Impurity Coverage by a Process Specific Assay Kit for Its Suitability for Use during Late Phase Manufacturing of an Investigational Therapeutic Fc-Fusion Protein
Favorite
10:30 AM – 11:30 AM
ET
(T1030-08-53) Impact of Microcrystalline Cellulose Grade and Vibrational Feeding Assistance on Loss-in-Weight Continuous Feeding
Favorite
10:30 AM – 11:30 AM
ET
(T1030-08-54) Addressing Particulate Matter in Protein Therapeutics
Favorite
10:30 AM – 11:30 AM
ET
(T1030-08-55) Biomolecule Characterization Using UV-Vis Spectroscopy: A Focus on Thermal Stability of Nucleic Acids and Proteins
Favorite
10:30 AM – 11:30 AM
ET
(T1030-09-56) Cellular Uptake Mechanism of Hollow Polydopamine Nanoparticles, Nanosac
Favorite
10:30 AM – 11:30 AM
ET
(T1030-09-57) Evaluating the Potential of X-Ray Microscopy (XRM) as a Non-destructive Technique for the Characterization of Dry Powder Inhaler (DPI) Formulations
Favorite
10:30 AM – 11:30 AM
ET
(T1030-09-58) Comparing the Performance of Wet and Dry Polymer Binders in High Shear Wet Granulation and Twin-Screw Granulation Processes
Favorite
10:30 AM – 11:30 AM
ET
(T1030-09-59) Development of a Fast and Robust LC-MS/MS Method for Simultaneous Analysis of a Wide Range of Antibiotics: A Cost-Effective Solution for Pharmaceuticals
Favorite
10:30 AM – 11:30 AM
ET
(T1030-09-60) Investigation into How Solvent Selection Affects the Metastable Zone of Paracetamol During a Thermally Controlled Recrystallisation
Favorite
10:30 AM – 11:30 AM
ET
(T1030-09-61) A Novel Method for Coating of Fine Particles to Time-Saving
Favorite
10:30 AM – 11:30 AM
ET
(T1030-09-62) Interconversion Kinetic Study to Assess Class II Atropisomeric Drug Development Challenges
Favorite
10:30 AM – 11:30 AM
ET
(T1030-10-63) Predictive Power and Operational Use of SCISSOR to Streamline SC Biologics Drug Development
Favorite
10:30 AM – 11:30 AM
ET
(T1030-10-64) Mathematical Modeling-Based Calibration-Free Estimation of Receptor Expression and Binding Kinetics of Antibody Biotherapeutics Based on Time Evolution of Fluorescence Profile
Favorite
10:30 AM – 11:30 AM
ET
(T1030-10-65) A Review of Immunogenicity and Its Effect on Efficacy and Safety of Biologics as Reported on the Prescribing Label to Support Strategic Assessment and Planning Labeling Communications
Favorite
10:30 AM – 11:30 AM
ET
(T1030-10-66) Identifying Critical Parameters for Physiological Based Pharmacokinetic Modeling of Naloxone Hydrochloride Nasal Sprays
Favorite
10:30 AM – 11:30 AM
ET
(T1030-10-67) Pharmacokinetic Characterization of ETN101, a Novel Anti-cancer Agent and Its Metabolites in Rats and Dogs
Favorite
10:30 AM – 11:30 AM
ET
(T1030-10-68) Machine Learning-Based Prediction of Aldehyde Oxidase Activity in Multiple Species
Favorite
10:30 AM – 11:30 AM
ET
(T1030-10-69) Evaluating the Relative Contribution of OATP2B1 Transporter on Rosuvastatin Pharmacokinetic Drug-Drug Interactions Using Mechanistic and Physiologically Based Pharmacokinetic Modeling
Favorite
10:30 AM – 11:30 AM
ET
(T1030-11-70) Amorphous Solid Dispersions of Cinnarizine – The Influence of Polymer Type and Manufacturing Method on Drug Solubility, Partition Coefficient and Stability
Favorite
10:30 AM – 11:30 AM
ET
(T1030-11-71) Development of a Skin Patch of Baclofen for Sustained Management of Multiple Sclerosis Associated Spasticity
Favorite
10:30 AM – 11:30 AM
ET
(T1030-11-72) Enhancing the Oral Bioavailability of a Novel Anti-tuberculosis Drug Candidate, Quabodepistat, via Cocrystallization and Mechanistic Analysis of Differences in Bioavailability between Two Cocrystals
Favorite
10:30 AM – 11:30 AM
ET
(T1030-11-73) Industry Understanding for Overcoming Challenges to Demonstrate IVPT Sensitivity by Dose Amount and Dose Duration Modulation as per FDA Draft Guidance for Topical Drug Products
Favorite
10:30 AM – 11:30 AM
ET
(T1030-11-74) MRI Imaging of SLS 3D Printed Tablets in the Gastrointestinal Tract of Humans
Favorite
10:30 AM – 11:30 AM
ET
(T1030-11-75) Simplified Formulation of Dietary Supplements Using High Functionality Clean Label Excipients – Case Studies
Favorite
10:30 AM – 11:30 AM
ET
(T1030-11-76) The Physicochemical Properties and Morphological Changes of PLGA-PEG Nanoparticles During Long-Term In Vitro Release
Favorite
10:30 AM – 11:30 AM
ET
(T1030-12-77) Developing an In Situ Hyaluronic Acid-Tyramine Hydrogel Platform to Deliver Extracellular Vesicles
Favorite
10:30 AM – 11:30 AM
ET
(T1030-12-79) Extrusion of Customized PLLA Filaments Reinforced with Zinc Oxide Nanoparticles for Fabrication of 3D Anti-tumor Printlets
Favorite
10:30 AM – 11:30 AM
ET
(T1030-12-80) Use of the Time–Temperature–Transformation Diagram to Evaluate the Role of Molecular Mobility on the Drug Stability in Amorphous Solid Dispersions
Favorite
10:30 AM – 11:30 AM
ET
(T1030-12-82) A Novel Binder Designed to Enable Widespread Adoption of Twin Screw Melt Granulation (TSMG)
Favorite
10:30 AM – 11:30 AM
ET
(T1030-12-83) Preparation and Aerodynamic Performance Evaluation of PLGA Microparticle with Dimple Surface
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-04) Solubility Enhancement of Atorvastatin Calcium Using Cyclodextrin
Favorite
10:30 AM – 11:30 AM
ET
(T1030-08-51) Development and Validation of Discriminatory Release Method for Intramammary Drug Products as a Part of In Vitro Quality Metrics
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-01) Acoustic Levitation: A Novel Experimental Tool to Study Drying Kinetics and Particle Formation of Pharmaceutical Excipients
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-03) Evaluating the Versatility of the New High Molecular Weight HPC in Dual Active Diabetic Controlled Release Dosages
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-04) Novel Abuse-Deterrent Tablet to Combat Opioid Abuse: A Hot Melt Extrusion Approach
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-06) Cyclodextrin Modulation of Lanreotide Gel Formation and Diffusional Release from an Emulated Subcutaneous Delivery Device
Favorite
11:30 AM – 12:30 PM
ET
(T1130-02-08) An Oleic Acid-Conjugated Vaccine Antigen for Enhanced Physicochemical Properties and Thermal Stability via Self-Assembled Nanonization
Favorite
11:30 AM – 12:30 PM
ET
(T1130-02-09) Design of Hyaluronic Acid-Coated Nanoliposomes for Active Targeting of Ibrutinib
Favorite
11:30 AM – 12:30 PM
ET
(T1130-02-10) Enhancing Aqueous Solubility of BCS Class II Drugs Through a Dual Approach of Salt Formation and Amorphous Solid Dispersion
Favorite
11:30 AM – 12:30 PM
ET
(T1130-02-11) Formulation Development and Characterization of Dual Drug Loaded Hot-Melt Extruded Inserts for Better Ocular Therapeutic Outcomes: Sulfacetamide/Prednisolone
Favorite
11:30 AM – 12:30 PM
ET
(T1130-02-12) Nitric Oxide Releasing Albumin Nanoclusters for Treating Methicillin-Resistant
staphylococcus aureus
Infected Cutaneous Wound
Favorite
11:30 AM – 12:30 PM
ET
(T1130-02-13) Rapid Production of Personalized Medicines Using Tomographic Volumetric 3D Printing
Favorite
11:30 AM – 12:30 PM
ET
(T1130-03-15) Albumin corona Improves Colloidal Stability of Nanosac, the Non-cationic Polyphenol Gene Carrier
Favorite
11:30 AM – 12:30 PM
ET
(T1130-03-16) Deaeration Enhances the Cryoprotective Effect of Tween 80 on Denaturation of Bovine IgG during Thin-Film Freezing
Favorite
11:30 AM – 12:30 PM
ET
(T1130-03-17) Transcytosis Mediated Deep Tumor Penetration for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer
Favorite
11:30 AM – 12:30 PM
ET
(T1130-03-18) Bioequivalence Deficiencies Observed in Sucralfate Oral Suspension Generic Applications: An In-Depth Analysis of the Deficiencies Identified to Help Improve the Quality of Future Submissions
Favorite
11:30 AM – 12:30 PM
ET
(T1130-03-20) Fast Tablet Hard Coating with Xylitol
Favorite
11:30 AM – 12:30 PM
ET
(T1130-03-21) Use of High-Pressure Homogenization to Prepare a Nano-suspension for Intravenous Administration
Favorite
11:30 AM – 12:30 PM
ET
(T1130-04-22) The Effect and Distribution of Amorphous Nanosilica Particle in the Brain and Microglial Cells
Favorite
11:30 AM – 12:30 PM
ET
(T1130-04-23) The Response of an Orthotopic Lung Cancer Xenograft Model to Cisplatin
Favorite
11:30 AM – 12:30 PM
ET
(T1130-04-24) Downregulated Expression Levels of miR-451a and miR-185-5p as Potential Biomarkers for Coronavirus Disease 2019 (COVID-19) Severity
Favorite
11:30 AM – 12:30 PM
ET
(T1130-04-25) Extended In Vitro-In Vivo Correlation (IVIVC) Model to Predict the Pharmacokinetics of Ticagrelor Sustained-Release Formulations
Favorite
11:30 AM – 12:30 PM
ET
(T1130-04-26) Investigation of a Novel Iron Chelator: A Pharmacokinetic and Pharmacodynamic Study
Favorite
11:30 AM – 12:30 PM
ET
(T1130-04-27) Anticancer Effects of Proteins and miRNAs Picked out by Proteomic Analysis of NK Cell-Derived EVs in Combination with Carboplatin in Resistant Lung Cancer: Role of PDL1/PD-1, SOD2, PARP, NF-kB and SET
Favorite
11:30 AM – 12:30 PM
ET
(T1130-04-28) Periplasmic Target Site Penetration Rates of Four β-Lactamase Inhibitors in Klebsiella Pneumoniae Carbapenemase-2 (KPC-2) Producing
Klebsiella pneumoniae
Favorite
11:30 AM – 12:30 PM
ET
(T1130-05-30) Development of a Targeted Peptide-Drug Conjugate for the Treatment of Glioblastoma
Favorite
11:30 AM – 12:30 PM
ET
(T1130-05-31) Development and Validation of Quantitative Analysis Method for Testosterone Derivatives in Natural musk(Moschus) Using GC-MS
Favorite
11:30 AM – 12:30 PM
ET
(T1130-05-32) Global Identification of OATP1B1-Associated Proteins and Implications of Calcineurin Inhibition in Time-Dependent OATP1B1 Inhibition
Favorite
11:30 AM – 12:30 PM
ET
(T1130-05-33) High-Density Lipoprotein Mimetic Peptide 4F Reduces Amyloid Beta Peptide Accumulation in the Blood-Brain Barrier Endothelium of Alzheimer’s disease brain
Favorite
11:30 AM – 12:30 PM
ET
(T1130-06-36) Method Development of BI-X ADC Gyrolab Assay for the Determination of Anti-BI-X Antibodies
Favorite
11:30 AM – 12:30 PM
ET
(T1130-06-37) Establishment of an LC-MS/MS Method for Quantification of Lifitegrast in Rabbit Ocular Tissues and Its Application to Pharmacokinetic Study
Favorite
11:30 AM – 12:30 PM
ET
(T1130-06-38) Development and Validation of a Novel ECL Method for the Quantitative Detection of Complement C3 in Human Serum
Favorite
11:30 AM – 12:30 PM
ET
(T1130-06-39) Targeted Profiling of Lipid Mediators as Serum Biomarkers of Inflammation in a Case Study
Favorite
11:30 AM – 12:30 PM
ET
(T1130-08-49) Excipient Characterization: Solid Density and Surface Area
Favorite
11:30 AM – 12:30 PM
ET
(T1130-08-51) Multivariate Analysis of Granule Size Data from Continuous Granulation Screening and Response Surface Studies: A Tool for Process Understanding
Favorite
11:30 AM – 12:30 PM
ET
(T1130-08-52) Effect of Packing Fraction on Permeability of Powders for Pharmaceutical Processes
Favorite
11:30 AM – 12:30 PM
ET
(T1130-08-53) Microfluidic-Assisted Preparation of ARV 825 and Osimertinib Loaded Liposomal Formulation as a Potential System for Colorectal Cancer Therapy
Favorite
11:30 AM – 12:30 PM
ET
(T1130-08-55) Monolayer Tablet Compression Process Optimization Using a Response Surface Method Design of Experiments
Favorite
11:30 AM – 12:30 PM
ET
(T1130-09-56) Impact of Relative Humidity on the Flow Behaviour of Pharmaceutical Materials during Powder Feeding
Favorite
11:30 AM – 12:30 PM
ET
(T1130-09-57) High-Throughput Characterization of Gene Therapy Products by SEC-MAL
Favorite
11:30 AM – 12:30 PM
ET
(T1130-09-58) Investigation of Formulation of Mini-tablets with Direct Compressible Excipients
Favorite
11:30 AM – 12:30 PM
ET
(T1130-09-59) Nitroso Drug Substances Related Impurities Analysis in Active Pharmaceutical Ingredients
Favorite
11:30 AM – 12:30 PM
ET
(T1130-09-60) A Study on the Modernization of Analytical Methods in Korean Pharmacopoeia
Favorite
11:30 AM – 12:30 PM
ET
(T1130-09-61) Reliable HPLC Method for the Simultaneous Determination of Aspirin and Associated Related Substances in Drug Substance and Tablet Formulation
Favorite
11:30 AM – 12:30 PM
ET
(T1130-09-62) Manufacture of Low-Dose Rapidly Disintegrating Dosages Using 3DP Binder Jetting
Favorite
11:30 AM – 12:30 PM
ET
(T1130-10-63) Retrospective Safety Evaluation of Tyrosine Kinase Inhibitor Products When Administered in Single Dose in Crossover Studies to Healthy Volunteers
Favorite
11:30 AM – 12:30 PM
ET
(T1130-10-64) Explore Gender Differences in Perfluorooctanoic Acid Using Ontogeny Integrated Physiologically-Based Pharmacokinetic Model in Rats
Favorite
11:30 AM – 12:30 PM
ET
(T1130-10-65) A Phase 1, Randomized, Open-Label, Single-Dose, Crossover, Relative Bioavailability Study of Omaveloxolone Intact Capsules versus Capsule Contents Sprinkled on Applesauce in Healthy Adult Subjects
Favorite
11:30 AM – 12:30 PM
ET
(T1130-10-66) Factors Affecting Peripheral Neuropathy Induced by Nab-paclitaxel in Patients with Pancreatic Cancer
Favorite
11:30 AM – 12:30 PM
ET
(T1130-10-67) Development of a Novel HPLC Method for the Sensitive Detection of Quercetin and Related Flavonoids in the Treatment of Myotonic Dystrophy
Favorite
11:30 AM – 12:30 PM
ET
(T1130-10-68) EGFR-Targeted Nanoliposomes of Synergistic Oncogenic Protein Degrader Combination: Significant Inhibition of Tumor Growth in Lung-Tumor Bearing Mice
Favorite
11:30 AM – 12:30 PM
ET
(T1130-10-69) Identification of Drug Metabolizing Enzymes that Catalyze Formation of a Novel Oxidative Metabolite from 7-ethoxycoumarin
Favorite
11:30 AM – 12:30 PM
ET
(T1130-11-70) Application of Colloidal MCC and Xanthan in Challenging Suspension Formulation
Favorite
11:30 AM – 12:30 PM
ET
(T1130-11-71) Predicting the Stability of Lyophilised Protein Mixtures with Terahertz Spectroscopy
Favorite
11:30 AM – 12:30 PM
ET
(T1130-11-72) Estimation of Drug Apparent Solubility in Gastric Contents after the Standard High-Calorie High-Fat Meal: Comparison of Data in Biorelevant Media with Data in Aspirates
Favorite
11:30 AM – 12:30 PM
ET
(T1130-11-73) Influence of Drug Load and Surfactant Concentration on the Release Performance of Ternary Amorphous Solid Dispersions
Favorite
11:30 AM – 12:30 PM
ET
(T1130-11-74) Multi-targeted Nanomedicine with Synergistic Doxorubicin and Oligo Hyaluronic Acid for Enhancing Anti-tumor Immunity in the Metastatic Triple-Negative Breast Cancer
Favorite
11:30 AM – 12:30 PM
ET
(T1130-11-75) Sonoprecipitation Synthesis of a Multifunctional Prodrug Nanosuspension Using a Quality by Design Approach
Favorite
11:30 AM – 12:30 PM
ET
(T1130-12-77) Vitamin D and Insulin Microparticle Incorporation into 3D-Printed Gene-Activated Calcium Phosphate Cement Scaffolds for Bone Regeneration Applications
Favorite
11:30 AM – 12:30 PM
ET
(T1130-12-78) Particle Engineering of Large Surface Area, Low Bulk Density, High Drug Load Particles of Poorly Water-Soluble Drugs for Depot Delivery at the Site of Disease
Favorite
11:30 AM – 12:30 PM
ET
(T1130-12-79) Development of Calcium Silicate Film-Coated Tablet as a Coloring Agent
Favorite
11:30 AM – 12:30 PM
ET
(T1130-12-80) Hot-Melt Extrusion of Simvastatin-Based Amorphous Solid Dispersions with PVP-VA and HPMC-AS
Favorite
11:30 AM – 12:30 PM
ET
(T1130-12-81) Lipophilic Copper Complex for Local Controlled Release of Nitric Oxide from Circulating Nitrites and S-nitrosothiols
Favorite
11:30 AM – 12:30 PM
ET
(T1130-12-82) Quality by Design (QbD) Based Formulation and Process Optimization for a Direct Blend Process: A Risk Based Industrial Approach
Favorite
11:30 AM – 12:30 PM
ET
(T1130-12-83) Exploration of Synergistic Polymer Combinations for Ocular Drug Delivery
Favorite
11:30 AM – 12:30 PM
ET
(T1130-05-34) Digestion Is an Important Element for Absorption of Cinnarizine from Supersaturated Lipid-Based Type II Formulations
Favorite
11:30 AM – 12:30 PM
ET
(T1130-08-50) Highly Protein-Loaded Melt Extrudates Produced by Small-Scale Ram and Twin-Screw Extrusion - Evaluation of Extrusion Process Design on Protein Integrity by Experimental and Numerical Approaches
Favorite
11:30 AM – 12:30 PM
ET
(T1130-11-76) Loading of Minoxidil to Extracellular Vesicles to Enhance the Transdermal Delivery to Hair Follicle
Favorite
12:30 PM – 1:30 PM
ET
(T1230-01-02) Immunity for the Long Haul: Exploring Cross-Protectivity against Emerging Strains upon Vaccination with Gonococcal Vaccine Microparticles in Mice
Favorite
12:30 PM – 1:30 PM
ET
(T1230-01-03) Novel Expandable Platform for Retentive Drug Delivery Systems
Favorite
12:30 PM – 1:30 PM
ET
(T1230-01-04) Evaluation of Critical Quality Attributes (CQA’s) of Carbomer Based Topical Hydro Gels with Process Analytical Technique (PAT)
Favorite
12:30 PM – 1:30 PM
ET
(T1230-02-08) Application of Ac-Di-Sol® SD-711 in Orally Disintegrating Tables (ODTs): Performance Comparison of Croscarmellose Sodium and Crospovidone
Favorite
12:30 PM – 1:30 PM
ET
(T1230-02-09) Development and In Vitro Evaluation of Donepezil, Memantine and siRNA Encapsulated Liposomes
Favorite
12:30 PM – 1:30 PM
ET
(T1230-02-10) Evaluating the Dissolution of Commercially Available Metered Dose Inhaler (MDI) Drug Products from Realistic In Vitro Experiments
Favorite
12:30 PM – 1:30 PM
ET
(T1230-02-11) Formulation Development and In-Use Sprinkle-on-the-Food Stability of Delayed-Release Pellets in Capsules: A Case Study
Favorite
12:30 PM – 1:30 PM
ET
(T1230-02-12) Non-haemolytic Nanoemulsions Development and Characterization for Novel Anti-prostate Cancer Compound PC257
Favorite
12:30 PM – 1:30 PM
ET
(T1230-02-13) Reduction of Blood Pressure in the Spontaneously Hypertensive Rats via the Nose-to-Brain Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA
Favorite
12:30 PM – 1:30 PM
ET
(T1230-03-15) Controlled Release of Monoclonal Antibodies from Long-Acting PLGA-Coated Implants
Favorite
12:30 PM – 1:30 PM
ET
(T1230-03-16) Conjugation Chemistry of Antibody-Liposome Conjugates Affects Performance via Complement Activation and Mechanisms Thereof
Favorite
12:30 PM – 1:30 PM
ET
(T1230-03-17) FDM 3D Printing Tablets Containing Iron Oxide Nanoparticles to Treat Iron Deficiency
Favorite
12:30 PM – 1:30 PM
ET
(T1230-03-18) Application of Hot Melt Extrusion Technology for the Preparation of Carbamazepine Extended-Release Tablets
Favorite
12:30 PM – 1:30 PM
ET
(T1230-03-20) Development of Stable Nanoemulsion Formulation as an Ophthalmic Drug Delivery System for Cannabinoids
Favorite
12:30 PM – 1:30 PM
ET
(T1230-03-21) Applicability of Ryshkewitch-Duckworth Based Models to Predict the Tensile Strength of Compacted Mixtures
Favorite
12:30 PM – 1:30 PM
ET
(T1230-04-22) The Paracrine Action of Mutant p53 in Breast Cancer
Favorite
12:30 PM – 1:30 PM
ET
(T1230-04-24) Hyaluronic Acid Nanogel Cancer Vaccine: Powerful and Versatile Priming Tool for Combinational T Cell Therapy
Favorite
12:30 PM – 1:30 PM
ET
(T1230-04-26) Mice Deficient in Interleukin 6 (IL-6) Show Improved Short-Term versus Long Term Memory following Methamphetamine Treatment
Favorite
12:30 PM – 1:30 PM
ET
(T1230-05-29) Finding the Alternative Path: Formulation Strategies for Sustained Release of Challenging Small Molecule Compounds
Favorite
12:30 PM – 1:30 PM
ET
(T1230-05-30) Enhanced Codelivery of Gefitinib and Azacitidine for Treatment of Metastatic-Resistant Lung Cancer Using Biodegradable Lipid Nanoparticles
Favorite
12:30 PM – 1:30 PM
ET
(T1230-05-31) Pharmacokinetics and Interspecies Scaling of Semaglutide, a GLP-1 Receptor Agonist
Favorite
12:30 PM – 1:30 PM
ET
(T1230-05-32) Regulation of OATP1B3 Transport Function via Protein Acetylation
Favorite
12:30 PM – 1:30 PM
ET
(T1230-05-33) Renal Monocarboxylate Transporter Expression in Response to Female Sex and Cross-Sex Hormone Treatment
Favorite
12:30 PM – 1:30 PM
ET
(T1230-06-36) Development and Validation of an LC-MS/MS Method for the Quantification of Hydrogen Sulfide in Isolated Tissues from Porcine Eyes
Favorite
12:30 PM – 1:30 PM
ET
(T1230-06-37) Expansion of the Human Immuno-Oncology Assay Portfolio on a Multiplexed Electrochemiluminescence Platform
Favorite
12:30 PM – 1:30 PM
ET
(T1230-06-38) Performance of a Digoxigenin Antibody-Based Electrochemiluminescent Hybridization Assay: A HELISA Alternative for Low Femtomolar Detection of an Antisense Oligonucleotide
Favorite
12:30 PM – 1:30 PM
ET
(T1230-06-39) Prediction of Hematocrit through Potassium Measurement in Whole Blood Using Volumetric Absorptive Microsampling
Favorite
12:30 PM – 1:30 PM
ET
(T1230-08-49) Addressing the Challenges of Industrial Manufacturing of Lipid-Based Complex Injectables: Fine-Tuning of Membrane Fluidity Using Quality-by-Design as a Tool to Enhance Process Effectiveness
Favorite
12:30 PM – 1:30 PM
ET
(T1230-08-50) Strength Evaluation of Pharmaceuticals and PTP Packaging
Favorite
12:30 PM – 1:30 PM
ET
(T1230-08-51) Common Deficiencies with Spray Dried Dispersion Intermediates for Solid Oral Drug Products Assessed by the FDA
Favorite
12:30 PM – 1:30 PM
ET
(T1230-08-52) LC and LCMS Solutions for Sample Preparation, and Data Analytics to Advance Oligonucleotide Therapy Development
Favorite
12:30 PM – 1:30 PM
ET
(T1230-08-53) Application of 3D Printing Technology for Development of Dose Adjustable Geriatric and Pediatric Formulation of Celecoxib
Favorite
12:30 PM – 1:30 PM
ET
(T1230-08-54) Development of 3D-Printed Bicompartmental Tablets by Dual Fused Deposition Modelling (FDM) for Site-Specific Colon Drug Delivery
Favorite
12:30 PM – 1:30 PM
ET
(T1230-08-55) Long-Term Stability of In-House Sunscreen Formulations
Favorite
12:30 PM – 1:30 PM
ET
(T1230-09-56) Encapsulation of Low Molecular Weight Chemokines via Single Emulsion Technique
Favorite
12:30 PM – 1:30 PM
ET
(T1230-09-57) Analytical Quality by Design Based Method Development for the Analysis of Cold and Cough Formulations
Favorite
12:30 PM – 1:30 PM
ET
(T1230-09-58) Systematic Method Development of Deferoxamine Mesylate Forced Degradation Sample
Favorite
12:30 PM – 1:30 PM
ET
(T1230-09-59) A Continuous Twin Screw Melt Granulation Process for High Drug Loading Oral Dosage Formulation
Favorite
12:30 PM – 1:30 PM
ET
(T1230-09-60) Improved Biopharmaceutical Peptide Mapping Workflows Using a Novel Autolysis-Resistant Trypsin Enzyme
Favorite
12:30 PM – 1:30 PM
ET
(T1230-09-61) Optimization of the Continuous Direct Compression Process with Special Focus on Filling Devices
Favorite
12:30 PM – 1:30 PM
ET
(T1230-09-62) Enhanced Mechanistic Understanding of Drug Product Performance Via High-Resolution Imaging and AI Image Analytics
Favorite
12:30 PM – 1:30 PM
ET
(T1230-10-63) TV-46000, a Novel Long Acting Injectable (LAI) Formulation of Risperidone, Forms a Stable and Robust Subcutaneous Depot, Even under Extreme Conditions: Prediction from Dog and Minipig to Human
Favorite
12:30 PM – 1:30 PM
ET
(T1230-10-64) Scientific and Regulatory Considerations of Applying Morphologically Directed Raman Spectroscopy in Bioequivalence Assessment for Generic Orally Inhaled and Nasal Drug Products
Favorite
12:30 PM – 1:30 PM
ET
(T1230-10-65) A Survey of Prevalence of Pediatric Dosing for Biologics
Favorite
12:30 PM – 1:30 PM
ET
(T1230-10-66) Addressing the MicroSampling Sensitivity Challenge in DMPK Studies Using Vacuum Jacketed Column UHPLC-cyclic Ion Mobility MS
Favorite
12:30 PM – 1:30 PM
ET
(T1230-10-67) Pharmacokinetic Profiles of Paynantheine and Its Diastereomer, Isopaynantheine, in Sprague-Dawley Rats
Favorite
12:30 PM – 1:30 PM
ET
(T1230-10-68) Mechanistic Elucidation of Pharmacokinetic Effects of Target-Mediated Drug Disposition (TMDD) for Small Molecule VAP-1 Inhibitor
Favorite
12:30 PM – 1:30 PM
ET
(T1230-10-69) Metabolite Identification of Nucleoside Analog Prodrugs in Biological Matrix by Derivatization Coupled with Radio-Detector and Mass Spectrometry
Favorite
12:30 PM – 1:30 PM
ET
(T1230-11-70) Application of Physiologically Based Pharmacokinetic Modeling to the Prediction of In Vitro and In Vivo Permeation of the UV Filter Octocrylene
Favorite
12:30 PM – 1:30 PM
ET
(T1230-11-71) Development of Cannabidiol-Loaded Nanostructured Lipid Carriers as an Approach for Potential Solubility Enhancement
Favorite
12:30 PM – 1:30 PM
ET
(T1230-11-72) Evaluation of Developmental TiO2 Free High Productivity and High Opacity Coating System at Different Scales
Favorite
12:30 PM – 1:30 PM
ET
(T1230-11-73) Injectable Antibacterial Dressings for the Prevention of Bacterial Biofilm in Chronic Rhinosinusitis (CRS)
Favorite
12:30 PM – 1:30 PM
ET
(T1230-11-74) Novel Gene Therapy for Drug-Resistant Melanoma: Synergistic Combination of PTEN Plasmid and BRD4 PROTAC Loaded Lipid Nanocarriers
Favorite
12:30 PM – 1:30 PM
ET
(T1230-11-75) Spray Drying (SD) and Hot Melt Extrusion (HME) for the Preparation of Amorphous Solid Dispersions (ASDs)
Favorite
12:30 PM – 1:30 PM
ET
(T1230-11-76) Calcium Carbonate as an Alternative to Titanium Dioxide in Coating: The Importance of Particle Engineering
Favorite
12:30 PM – 1:30 PM
ET
(T1230-12-77) Analytical Characterization for Nucleic Acid Therapy: A Case Study
Favorite
12:30 PM – 1:30 PM
ET
(T1230-12-79) P188 – Polymeric Carrier for Solid Dispersion Enabling Formulations of PROTACs
Favorite
12:30 PM – 1:30 PM
ET
(T1230-12-80) Calorimetric Investigation on the Disintegration Process of Pharmaceutical Tablets
Favorite
12:30 PM – 1:30 PM
ET
(T1230-12-81) Development of a Fixed-Dose Combination Using Concurrent Twin-Screw Hot Melt Extrusion and Melt Granulation: Optimization of Polymer-Diluent Combinations for Enhanced Drug Delivery
Favorite
12:30 PM – 1:30 PM
ET
(T1230-12-82) Evaluation of Polymeric Excipients for Stabilization of High Drug Loaded Solid Dispersions of Itraconazole
Favorite
12:30 PM – 1:30 PM
ET
(T1230-12-83) In Vivo Studies of Letrozole Non-aqueous Nano Emulgel Transdermal Delivery Systems
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-03) Increasing Oxidative Stability with High Purity Excipients Used in Ophthalmic Formulations
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-04) Demonstrating the Utility of a New High Molecular Weight HPC to Make Smaller Modified Release Tablets
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-05) Evaluation of the Compatibility of Capsugel® Enprotect® Capsules with Solid Phase Excipients to Accelerate Developments of New Enteric Drug Products
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-06) Statistical Optimization of Stable Quercetin Nanoparticles for Tumor Targeting
Favorite
1:30 PM – 2:30 PM
ET
(T1330-02-09) Development of 4-phenylbutyric Acid Microsponge Formulations as a Potential Antidote for Skin Injury Due to Chemical Warfare Agents
Favorite
1:30 PM – 2:30 PM
ET
(T1330-02-10) Evaluating the Impact of an Ultra-High Solids Film Coating System on Process Times and Tablet Aesthetics
Favorite
1:30 PM – 2:30 PM
ET
(T1330-02-11) Formulation of Cocrystal and Amorphous Solid Dispersion Printlets Developed by Hot Melt Extrusion Paired Fused Deposition Modeling for Dissolution Enhancement andStability of Ibuprofen
Favorite
1:30 PM – 2:30 PM
ET
(T1330-02-12) Novel Bio-Active Peroxisomal Proliferator Activating Receptor Gamma (PPARγ) Hydrogel for Periodontitis Management
Favorite
1:30 PM – 2:30 PM
ET
(T1330-03-15) Viable Eukaryotic Cell Dry Powders Prepared by Thin Film Freeze-Drying
Favorite
1:30 PM – 2:30 PM
ET
(T1330-03-16) pRNA Nanoparticles for Ocular Delivery: Pharmacokinetics and Pharmacodynamics After Subconjunctival Injection
Favorite
1:30 PM – 2:30 PM
ET
(T1330-03-17) Development of Hydroxypropyl Methylcellulose (HPMC)-Based, Titanium Dioxide (TiO
2
)-Free Coating
Favorite
1:30 PM – 2:30 PM
ET
(T1330-03-18) Equilibrium Solubility, Thermodynamic Modeling and Solubility Parameters of Itraconazole in Solvent Mixtures at Various Temperatures
Favorite
1:30 PM – 2:30 PM
ET
(T1330-03-19) Using Biorelevant Dissolution to Better Predict Bioavailability Issues
Favorite
1:30 PM – 2:30 PM
ET
(T1330-03-20) Orally Disintegrating Tablet Formulation of Vardenafil Taste-Masked Pellets
Favorite
1:30 PM – 2:30 PM
ET
(T1330-03-21) Quantitating the Contributions of the Particle Drift Effect to In Vitro FLUX and the Application of Particle Drift Flux to Predictive Modelling
Favorite
1:30 PM – 2:30 PM
ET
(T1330-04-22) Cell Culture Media Monitoring in Cell and Gene Therapy Supporting Upstream Bioprocessing
Favorite
1:30 PM – 2:30 PM
ET
(T1330-04-23) Discovery of Anti-Transforming Growth Factor β Receptor II (TGFβRII) Cyclic Peptides
Favorite
1:30 PM – 2:30 PM
ET
(T1330-04-24) Characterization of Particle Disposition following Intranasal Inoculation with a 3D Printed Device
Favorite
1:30 PM – 2:30 PM
ET
(T1330-04-25) The Impact of Surface Area per Volume Ratio on Drug Transport from Supersaturated Solutions of Ketoconazole
Favorite
1:30 PM – 2:30 PM
ET
(T1330-04-26) Effect of Omeprazole Administration on the Pharmacokinetics of Oral Extended-Release Nifedipine: Physiologically Based Pharmacokinetic Modeling
Favorite
1:30 PM – 2:30 PM
ET
(T1330-04-27) Effect of Propofol on Lipid Membrane Fluidity and Blood-Brain Barrier Permeability
Favorite
1:30 PM – 2:30 PM
ET
(T1330-06-36) Duplicate-Well vs Single-Well Analysis in Ligand Binding Assays (LBAs): A Retrospective Comparison of Method Validations and Nonclinical Toxicokinetic (TK) Sample Analyses Data
Favorite
1:30 PM – 2:30 PM
ET
(T1330-06-38) Rapid Quantitation of Docosahexaenoic Acid and Its Hydroxy Metabolites in Liver Cells Using Differential Mobility Separation (SelexION) Coupled with Liquid Chromatography Tandem Mass Spectrometry
Favorite
1:30 PM – 2:30 PM
ET
(T1330-06-39) Pharmacokinetic and Pharmacodynamic Correlations of Riluzole and Etoricoxib in a Long-Evan Rat Model with Traumatic Brain Injury
Favorite
1:30 PM – 2:30 PM
ET
(T1330-08-49) Continuous Processing of Liposomal Nanoparticles as Potential Reference Materials for Drug Product Development
Favorite
1:30 PM – 2:30 PM
ET
(T1330-08-50) Tailoring Drug Release from Long-Acting Contraceptive Levonorgestrel-Containing Intrauterine Systems
Favorite
1:30 PM – 2:30 PM
ET
(T1330-08-51) Polarized Light Microscopy: A Versatile Technique in the Reverse Engineering of Entacapone Tablets
Favorite
1:30 PM – 2:30 PM
ET
(T1330-08-52) Development of a Discrete Element Method (DEM) Model to Study the Impact of Process Parameters and Material Attributes on Continuous Twin Screw Wet Granulation Process
Favorite
1:30 PM – 2:30 PM
ET
(T1330-08-53) Personalized Orodispersible Films Using Extrusion 3D-Printing: An Impending Shift in Pharmaceutical Manufacturing
Favorite
1:30 PM – 2:30 PM
ET
(T1330-08-54) Do the pH-Stage Dissolution Tests Lie? Case Study of Duloxetine Hydrochloride Dissolution in the Small-Scale Setup
Favorite
1:30 PM – 2:30 PM
ET
(T1330-08-55) Novel Preparation Method of Spherical Drug-Containing Particles Using High Shear Melt Granulation; MALCORE®
Favorite
1:30 PM – 2:30 PM
ET
(T1330-09-56) In-Cell ELISA Assays to Assess Drug Relative Potency Using the Cytation Imaging Reader for Sample Analysis
Favorite
1:30 PM – 2:30 PM
ET
(T1330-09-57) Simultaneous Determination of Naphazoline Hydrochloride and Pheniramine Maleate Along with Their Related Compounds by High Performance Liquid Chromatography
Favorite
1:30 PM – 2:30 PM
ET
(T1330-09-58) Principle Component Analysis of Formulation Variations on Binder Jet 3D Printed Tablet
Favorite
1:30 PM – 2:30 PM
ET
(T1330-09-59) An Improved Multiple Headspace Extraction Workflow Using SIFT-MS
Favorite
1:30 PM – 2:30 PM
ET
(T1330-09-60) Performance of Pre-Filled Syringe Systems at Low Temperature
Favorite
1:30 PM – 2:30 PM
ET
(T1330-09-61) 3D Printed Medication: A Case Study on Personalization of Pediatric Arrhythmia Treatment
Favorite
1:30 PM – 2:30 PM
ET
(T1330-09-62) Mechanistic Determination of Tensile Strength of Shaped Tablets
Favorite
1:30 PM – 2:30 PM
ET
(T1330-10-64) Advancing Neuro-Regenerative Therapies: Scalable Manufacturing and Purification of Extracellular Vesicles for Treating Neurodegenerative Diseases
Favorite
1:30 PM – 2:30 PM
ET
(T1330-10-65) Tocilizumab Induced Immunosuppression in A Case of Adult-Onset Still’s Disease: Are These Newer Biologics Double Edged Sword?
Favorite
1:30 PM – 2:30 PM
ET
(T1330-10-67) Assay Development and Characterization of
T. gondii
Nucleoside Transporters in MDCK-II Cells
Favorite
1:30 PM – 2:30 PM
ET
(T1330-10-68) Effects of Clarithromycin on the Pharmacokinetics of Pitavastatin and Its Lactone Metabolite in Different SLCO1B1 Diplotypes
Favorite
1:30 PM – 2:30 PM
ET
(T1330-10-69) Evaluation of Applications for Topical Semisolid Drug Products with In Vitro Permeation Test and In Vivo Bioequivalence Study with Pharmacokinetic Endpoints
Favorite
1:30 PM – 2:30 PM
ET
(T1330-11-70) Are Globally Marketed Generic 1% Clotrimazole Creams Pharmaceutically Equivalent?
Favorite
1:30 PM – 2:30 PM
ET
(T1330-11-71) Development of Hot-Melt Extruded Solid Self-Nanoemulsifying Drug Delivery System for Improved Oral Delivery of Poorly Water-Soluble Drug Using Central Composite Design
Favorite
1:30 PM – 2:30 PM
ET
(T1330-11-73) Investigating and Optimizing the Influence of Process Parameters on Development of Polymeric Microparticles: A Quality-by-Design Approach
Favorite
1:30 PM – 2:30 PM
ET
(T1330-11-74) Novel LAAM Immediate Release Capsule for Treating Opioid Use Disorder
Favorite
1:30 PM – 2:30 PM
ET
(T1330-11-75) Stabilizing High Salt Content Suspensions with Colloidal Microcrystalline Cellulose and Xanthan
Favorite
1:30 PM – 2:30 PM
ET
(T1330-11-76) Development of an Iontophoresis-Coupled Microneedle Skin Patch of Naloxone for Emergency Treatment of Opioid Overdose
Favorite
1:30 PM – 2:30 PM
ET
(T1330-12-77) Delivery of Therapeutic Plant-Derived Exosomes to the Brain for the Treatment of Mental Health Disorders and CNS Injuries
Favorite
1:30 PM – 2:30 PM
ET
(T1330-12-78) Thermally Gelling Hypromellose Liquid Sprays for Oropharyngeal Targeting
Favorite
1:30 PM – 2:30 PM
ET
(T1330-12-79) Sweet Levofloxacin Acesulfame Crystals with Improved Compaction Property and Solvates Interconversion
Favorite
1:30 PM – 2:30 PM
ET
(T1330-12-80) Surfactant Selection in the Development of Oral Ternary Amorphous Solid Dispersions from the Perspective of Solubility and Supersaturation
Favorite
1:30 PM – 2:30 PM
ET
(T1330-12-82) Formulation and In Vitro Characterization of Orally Disintegrating Tablets of Drug Molecules with Varied Physicochemical Properties
Favorite
1:30 PM – 2:30 PM
ET
(T1330-12-83) Role of Polymers in the Physical and Chemical Stability of Amorphous Solid Dispersion: A Case Study of Carbamazepine
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-01) Osimertinib Immunoliposomes as Inhaled Therapy for Non-small Cell Lung Cancer Treatment
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-02) Design and Development of High Drug Loading Commercial Formulation for a Salt Drug Substance with High Propensity of Solid Form Conversion
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-03) Exploring the Potential of Inhaled Nano Therapy for Malignant Pleural Mesothelioma
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-04) Analysis and Simulation of In Vivo Nanoparticle Protein Carrier Pharmacokinetics
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-05) Influence of Kollicream
®
OD on Ibuprofen Skin Permeation and Retention
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-06) Systematic Screening of Pharmaceutical Co-crystals Using Experimental and Computational Tools
Favorite
2:30 PM – 3:30 PM
ET
(T1430-02-08) Bioadhesive and Sustained Release Epinephrine-Loaded Sodium Alginate Hydrogel Accelerates Hemostasis to Manage Gastrointestinal Bleeding
Favorite
2:30 PM – 3:30 PM
ET
(T1430-02-09) Development of a Hollow Vaginal Drug-Eluting Device Using Stereolithography 3D Printing for the Treatment of Recurrent Vulvovaginal Candidiasis
Favorite
2:30 PM – 3:30 PM
ET
(T1430-02-10) Evaluating Treatment Efficiency of RV and Kinase Inhibitor (KI) in Combination for Alzheimer’s disease: Cell Line Study
Favorite
2:30 PM – 3:30 PM
ET
(T1430-02-12) Novel Melting Point Depression Method to Predict Drug Dissolution during Melt Extrusion of PLGA Millifiber Implant
Favorite
2:30 PM – 3:30 PM
ET
(T1430-02-13) Roles of Protein Corona in Physicochemical Properties and Stability of pH-Triggering Self-Assembled Nanoparticles of Drug-Myristic Acid Conjugate
Favorite
2:30 PM – 3:30 PM
ET
(T1430-03-15) Beyond Conventional Boundaries: New Excipients for ASD Formulation
Favorite
2:30 PM – 3:30 PM
ET
(T1430-03-16) Temperature Variations and Impurities Preclude a Reliable Measurement of the Diffusion Interaction Parameter for Monoclonal Antibodies
Favorite
2:30 PM – 3:30 PM
ET
(T1430-03-17) Preparation and Evaluation of Temozolomide Solid Lipid Nanoparticles: Focus on Improvement in Bioavailability and Physiochemical Analysis for Decreased Toxic Effect in Glioblastoma Multiforme
Favorite
2:30 PM – 3:30 PM
ET
(T1430-03-18) Dual Drug-Loaded Cubosome Nanoparticles for Pulmonary Tuberculosis Treatment
Favorite
2:30 PM – 3:30 PM
ET
(T1430-03-19) Levofloxacin, a Complex Fluoroquinolone Drug and Its Organic Solvent-Free Journey to Amorphization
Favorite
2:30 PM – 3:30 PM
ET
(T1430-03-20) The Impact of Particle Size of the Drug Substance on Dissolution of Finished Product for the Treatment of Cushing’s Disease in Dogs
Favorite
2:30 PM – 3:30 PM
ET
(T1430-03-21) Phase Transitions and Apparent Acidity in HSA/Saline Solution during Freezing and Post Freeze-Drying
Favorite
2:30 PM – 3:30 PM
ET
(T1430-05-29) Chiral Separation of Triacyclglycerols Isomers by Supercritical Fluid Chromatography
Favorite
2:30 PM – 3:30 PM
ET
(T1430-05-30) The Use of Short 10 mm Columns for Ultra-fast LC-MS Analyses
Favorite
2:30 PM – 3:30 PM
ET
(T1430-05-31) Analysis of Pharmacogenetic Polymorphism Effect of ABCB1 2677G >T/A Through Molecular Modeling Approach
Favorite
2:30 PM – 3:30 PM
ET
(T1430-05-32) The Printability of an Alginate-Based Hydrogel and Its Compatibility with NIH-3T3 Cells
Favorite
2:30 PM – 3:30 PM
ET
(T1430-05-33) Engineering Human Liver Spheroids with Biomimetic Nanoscaffolds for Preclinical Test of Drug-Induced Liver Injuries
Favorite
2:30 PM – 3:30 PM
ET
(T1430-06-36) Immunogenicity Assessment: A Comparative Study between a Chemically Labeled and an Enzymatically Biotinylated rAAV9 Vector
Favorite
2:30 PM – 3:30 PM
ET
(T1430-06-37) Quantum Electrochemical Spectroscopy (QES): A Novel AI-Driven Spectroscopic Approach to Simplify Bioanalytical Development in the Pharmaceutical and Biotech Industries
Favorite
2:30 PM – 3:30 PM
ET
(T1430-06-38) Content Uniformity, Drug Quantification and Cross-Reactivity Analysis of Protein Loaded PGSU Implants Using Raman Spectroscopy and Reverse-Phase High Performance Liquid Chromatography (RP-HPLC)
Favorite
2:30 PM – 3:30 PM
ET
(T1430-06-39) A Process of Method Development for Tissue Homogenization and Analysis to Eliminate Binding and Matrix Effects Using Surrogate Matrices
Favorite
2:30 PM – 3:30 PM
ET
(T1430-06-40) Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Pharmacokinetics of PTH-IA in Mice
Favorite
2:30 PM – 3:30 PM
ET
(T1430-06-41) Research Strategy of Chiral PROTACs in Discovery Stage Based on Analysis Platforms of UPCC-MS/MS and UPLC-MS/MS
Favorite
2:30 PM – 3:30 PM
ET
(T1430-08-49) 3D Printing of Single and Multi-unit Containers for Dispensing Solid Dosage Forms
Favorite
2:30 PM – 3:30 PM
ET
(T1430-08-50) Analytical Case Studies for Processed-Induced and API-Related Nitrosamines in Finished Drug Products
Favorite
2:30 PM – 3:30 PM
ET
(T1430-08-52) Application of Twin-Screw Extrusion for Generating Polymorphs to Support Phase Mapping and Scale Up Crystallization of the Desired Form
Favorite
2:30 PM – 3:30 PM
ET
(T1430-08-53) Getting Sticky with It – Formulation Tenacity in 3D Printing
Favorite
2:30 PM – 3:30 PM
ET
(T1430-08-54) Determining the Effect of Blade Fouling on the Approach to Steady State and Final Residence Mass within a Continuous Blender
Favorite
2:30 PM – 3:30 PM
ET
(T1430-09-56) Using Experimentally Validated ML Modeling to Predict the Thawing Time of Biologics During Large Scale Freeze-Thawing Cycles
Favorite
2:30 PM – 3:30 PM
ET
(T1430-09-57) Driving Timely Clinical Development: Simulation-Based Process Development and Tech-Transfer for Mini-Tablets in Capsules
Favorite
2:30 PM – 3:30 PM
ET
(T1430-09-58) Compaction Simulation of SDI-Based Formulations to Enable Material-, Time-, and Cost-Sparing Technical Transfer
Favorite
2:30 PM – 3:30 PM
ET
(T1430-09-59) Regulatory Experience with Continuous Manufacturing and Real Time Release Testing for Dissolution in New Drug Applications
Favorite
2:30 PM – 3:30 PM
ET
(T1430-09-60) 2D-LC as A Novel Analytical Platform for the Characterization of Complex Drug Substances: A Case Study with Glatiramer Acetate
Favorite
2:30 PM – 3:30 PM
ET
(T1430-09-61) Identification of Levofloxacin Hydrates and Observation of Their Crystal-Form Transition in Drug Products by Terahertz Frequency-Domain Spectroscopy
Favorite
2:30 PM – 3:30 PM
ET
(T1430-09-62) Characterization of Intravenous Iron Supplements: Injectafer
®
Favorite
2:30 PM – 3:30 PM
ET
(T1430-10-63) Impact of Preparation Technique and Storage Condition on the Quality of Suspension Vehicles Used in Preclinical In Vivo Studies
Favorite
2:30 PM – 3:30 PM
ET
(T1430-10-64) Development of a Quantitative Systems Toxicology Model to Predict Drug-Induced Liver Injury in Pediatrics
Favorite
2:30 PM – 3:30 PM
ET
(T1430-10-65) Novel Biomarkers for Inflammatory Bowel Disease
Favorite
2:30 PM – 3:30 PM
ET
(T1430-10-66) Pharmacokinetics of Nervonic Acid, a Monounsaturated Fatty, in an Adrenoleukodystrophy (ALD) Mouse Model
Favorite
2:30 PM – 3:30 PM
ET
(T1430-10-67) Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells
Favorite
2:30 PM – 3:30 PM
ET
(T1430-10-68) Metabolite Identification of R14 in Rat Urine after a Single Oral Administration to Rats Using UPLC-TOF MS/MS
Favorite
2:30 PM – 3:30 PM
ET
(T1430-10-69) Using Simulation to Address Challenges in Bioequivalence Data Analysis for Drug Products Containing Endogenous Compounds
Favorite
2:30 PM – 3:30 PM
ET
(T1430-11-70) Assessing the Impact of Dry Particle Coating with Nano-Silica on Compaction Properties of Cohesive Active Pharmaceutical Ingredients
Favorite
2:30 PM – 3:30 PM
ET
(T1430-11-71) Development of Hydrogel Polymer-Based Bilayer Gastro-Retentive Modified-Release Tablets
Favorite
2:30 PM – 3:30 PM
ET
(T1430-11-72) Evaluation of Stability and Physical Parameters of Sitagliptin IR Tablets Coated with Different Titanium Dioxide Free Coating Systems
Favorite
2:30 PM – 3:30 PM
ET
(T1430-11-73) Investigating Phase Separation of Trehalose during Lyophilization of Proteins Using Solid State NMR
Favorite
2:30 PM – 3:30 PM
ET
(T1430-11-74) Novel NanoSensoGel Engineered for Prevention of Chemotherapeutic-Induced Ototoxicity and Associated Hearing Loss
Favorite
2:30 PM – 3:30 PM
ET
(T1430-11-75) Suitability of Isavuconazonium Sulfate as a Biopharmaceutics Classification System (BCS)-Based Biowaiver Candidate
Favorite
2:30 PM – 3:30 PM
ET
(T1430-12-77) Development of a Dual-Drug Conjugate for Site-Specific Delivery to Prostate Cancer
Favorite
2:30 PM – 3:30 PM
ET
(T1430-12-78) Preliminary Study of How Capsule Materials Influence the Physical Stability of Dried Powder Inhalers
Favorite
2:30 PM – 3:30 PM
ET
(T1430-12-79) Improving Oral Absorption of Rapidly Crystallizing Parent API Using Prodrug Strategy: Comparison of Phosphate Versus Glycine Based Prodrugs
Favorite
2:30 PM – 3:30 PM
ET
(T1430-12-80) Development and Application of USP Apparatus 3 for In Vitro Drug Release from a Paclitaxel Nanocrystal Formulation
Favorite
2:30 PM – 3:30 PM
ET
(T1430-12-81) Novel High Throughput Polymer Screening for Development of Amorphous Solid Dispersion
Favorite
2:30 PM – 3:30 PM
ET
(T1430-12-82) Personalized 3D Printing Earring Tap for Treating Affections Caused by Aesthetic Perforations
Favorite
2:30 PM – 3:30 PM
ET
(T1430-12-83) Design of a Re-Dispersible High Drug Load Amorphous ABT-530 Formulation: Impact of Formulation Composition on Processing and Performance
Favorite
3:30 PM – 4:30 PM
ET
(T1530-01-01) Application of Solid-State NMR and DSC in Evaluating the Effect of Intrinsic and Extrinsic Factors and Surface Energy of the 3D Printed Probe on Adhesion Properties of Transdermal Patches
Favorite
3:30 PM – 4:30 PM
ET
(T1530-01-02) Exploring the Properties of Hexagonal Liquid Crystalline Nanoparticles for Co-delivery of Dexamethasone Acetate and siRNA TNF-α
Favorite
3:30 PM – 4:30 PM
ET
(T1530-01-03) Influence of Polymer Miscibility on Drug Release from Microparticles Prepared Using a 3-Fluid Spray Drying Process
Favorite
3:30 PM – 4:30 PM
ET
(T1530-01-04) Design of Experiment Multi-level Categoric Design Model for Formulation Parameters’ Optimization of Raloxifene Hydrochloride Solid Dispersion Produced by Hot-Melt Extrusion
Favorite
3:30 PM – 4:30 PM
ET
(T1530-01-05) Personalized Polypill Using a New Flexible 3D Printed Design
Favorite
3:30 PM – 4:30 PM
ET
(T1530-01-06) Targeted Combination Therapy for Pancreatic Cancer Management
Favorite
3:30 PM – 4:30 PM
ET
(T1530-02-08) BIONDD
TM
Oral Capsule Delivery of Liraglutide with Bioavailability Comparable to Subcutaneous Injection and Development of Efficient In Vivo Model in Dogs to Test Feasibility of Other Biologic Drugs
Favorite
3:30 PM – 4:30 PM
ET
(T1530-02-09) Development of a Stable Intravenous Injectable Formulation of Highly Hydrolytic Molecule in a Co-Crystal with a Highly Hydrophobic (A1) and Highly Hydrophilic (A2) Drug Substance
Favorite
3:30 PM – 4:30 PM
ET
(T1530-02-10) Evaluation of Stability of Ion Exchange Resin Based Carrageenan Gummies
Favorite
3:30 PM – 4:30 PM
ET
(T1530-02-11) In Vivo Characterization and Bioequivalence Study of 3D Printed Tenofovir Disoproxil Fumarate Printlets
Favorite
3:30 PM – 4:30 PM
ET
(T1530-02-12) Optimization of Spray-Drying Process Parameters for the Preparation of PVP Microparticles Suitable for Nose-to-Brain Drug Delivery
Favorite
3:30 PM – 4:30 PM
ET
(T1530-02-13) Scalability of EUDRATEC
®
Fasteric, an Advanced Technology to Target the Duodenum for Improved Absorption
Favorite
3:30 PM – 4:30 PM
ET
(T1530-02-14) Application of Novel Supercritical Fluid Technology in Developing Albendazole Solid Dispersion
Favorite
3:30 PM – 4:30 PM
ET
(T1530-03-15) Enhancing Oral Absorption of a Poorly Water Soluble Anticancer Drug via Prodrug Modification
Favorite
3:30 PM – 4:30 PM
ET
(T1530-03-17) Preparation and Characterization of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Drug Delivery
Favorite
3:30 PM – 4:30 PM
ET
(T1530-03-18) Application of Hypromellose Phthalate (HPMCP) for the development of Esomeprazole 20mg Multiple Unit Pellet System (MUPS)
Favorite
3:30 PM – 4:30 PM
ET
(T1530-03-20) Vial Containment Systems for Gene Therapy Drug Products
Favorite
3:30 PM – 4:30 PM
ET
(T1530-03-21) A First-in-Human Assessment for TQS-168, Including Safety, Tolerability, Pharmacokinetics, Formulation Selection, and Food Effect in Healthy Volunteers
Favorite
3:30 PM – 4:30 PM
ET
(T1530-05-29) Discovery of a Deazaflavin Analog as Potent and Selective Inhibitor of Multidrug Resistance-Associated Protein 1 (MRP1)
Favorite
3:30 PM – 4:30 PM
ET
(T1530-05-30) Discovery of Oral Vaccine Adjuvant via Bioanalytical HTS Assays
Favorite
3:30 PM – 4:30 PM
ET
(T1530-05-31) A Novel Dissolution Model to Study the Release and Uptake of Oral Lymphotropic Drug Products
Favorite
3:30 PM – 4:30 PM
ET
(T1530-05-32) Topical Dexpanthenol Modulates Microbially Induced Inflammation in a 3D Corneal Model: A Proteomic Analysis
Favorite
3:30 PM – 4:30 PM
ET
(T1530-05-33) Characterizing the Pharmacological Mechanism of Agmatine in the Spinal Cord Using Calcium Imaging and NMDA-induced Behavioral Assays
Favorite
3:30 PM – 4:30 PM
ET
(T1530-06-36) An End-to-End One-Pot Immunoaffinity-LC-MS/MS Assay for Simultaneous Quantitation of Total and Conjugated Antibody Levels of Antibody-Drug Conjugates with Protease-Cleavable Linkers
Favorite
3:30 PM – 4:30 PM
ET
(T1530-06-37) A Study of the Effects of Water and other Modifier Additives on the SFC Separation of Ritonavir
Favorite
3:30 PM – 4:30 PM
ET
(T1530-06-38) Out of Endotoxin Box: Rethinking Pyrogens
Favorite
3:30 PM – 4:30 PM
ET
(T1530-06-39) A Two-Part Method for the Separation and Quantification of Free and Encapsulated ASOs by Hybridization ELISA
Favorite
3:30 PM – 4:30 PM
ET
(T1530-06-40) Analyzing Insulin Glargine Biosimilars: Stability, Degradation, and Structural Characterization
Favorite
3:30 PM – 4:30 PM
ET
(T1530-08-49) Capillary Mediated Vitrification (CMV) is a User-Friendly Alternative to Lyophilization for the Production of Thermostable Bio-molecules
Favorite
3:30 PM – 4:30 PM
ET
(T1530-08-51) Effect of Morphologies and Process Parameters on Aerodynamic Performance of Fluticasone Propionate in Dry Powder Inhaler
Favorite
3:30 PM – 4:30 PM
ET
(T1530-08-52) Continuous Manufacturing of Solvent-Free Cyclodextrin Inclusion Complexes for Enhanced Drug Solubility via Hot-Melt Extrusion: A Quality by Design Approach
Favorite
3:30 PM – 4:30 PM
ET
(T1530-08-53) The Effects of Aberrant Trisulfide Bond Formation in Therapeutic Proteins for Product Quality and Comparative Analytical Assessments
Favorite
3:30 PM – 4:30 PM
ET
(T1530-08-54) Critical Formulation Attributes of Naloxone Nasal Spray Products Affecting Nasal Permeation
Favorite
3:30 PM – 4:30 PM
ET
(T1530-08-55) Investigation Study of Color Change in Drug Tablets by Raman Spectroscopy
Favorite
3:30 PM – 4:30 PM
ET
(T1530-09-56) Points to Consider in the Development of Activity and Potency Assays for Enzyme Biotherapeutics
Favorite
3:30 PM – 4:30 PM
ET
(T1530-09-57) An Automated Process Analytical Interface to Estimate Tablet Porosity and Height Based on Terahertz Time-Domain Spectroscopy Reflection Measurements
Favorite
3:30 PM – 4:30 PM
ET
(T1530-09-58) Exploring Applications of Plant-Derived Polymers in Fused Deposition Modeling of Oral Pharmaceutical Tablets
Favorite
3:30 PM – 4:30 PM
ET
(T1530-09-59) Development of the Quantitative Prediction Model by Applying Chemometric and Artificial Intelligence in the Near-Infrared Spectrum as Pharmaceutical Process Analytical Technology
Favorite
3:30 PM – 4:30 PM
ET
(T1530-09-60) Impact of Vacuum Drum Filling Parameters on Dry Powder Inhaler Performance
Favorite
3:30 PM – 4:30 PM
ET
(T1530-09-61) Effect of Collagen Source on the In Vitro Performance of Collagen Implant
Favorite
3:30 PM – 4:30 PM
ET
(T1530-10-63) Prediction of Human PK for Multispecific Antibody TAVO412 Using Non-linear Population PK Model and Allometric Scaling
Favorite
3:30 PM – 4:30 PM
ET
(T1530-10-64) Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
Favorite
3:30 PM – 4:30 PM
ET
(T1530-10-65) Artificial Extracellular Matrices Containing Human Collagen for In Vitro Analysis of Formulations Intended for Subcutaneous Injection
Favorite
3:30 PM – 4:30 PM
ET
(T1530-10-66) A Regression Approach for Assessing Large Molecular Drug Concentration in Breast Milk
Favorite
3:30 PM – 4:30 PM
ET
(T1530-10-67) Ex Vivo Platforms (Perfused Liver/Kidney and Intestinal Tissue) including PBPK Modeling Enabling Human PK Predictions and Metabolite Synthesis
Favorite
3:30 PM – 4:30 PM
ET
(T1530-10-68) In Silico Predictive Modeling of the Pharmacokinetic (PK) Profiles of Nasal Sprays in Adults and Children
Favorite
3:30 PM – 4:30 PM
ET
(T1530-10-69) Evidence-Based Strategies for the Characterization of New Chemical Entity (NCE) In Vitro CYP and Non-CYP Enzyme Reaction Phenotyping at the Development Stage
Favorite
3:30 PM – 4:30 PM
ET
(T1530-11-70) Assessing the Impacts of Drug Loading and Polymer Type on In Vitro Dissolution and Flux Behavior of GDC-A Amorphous Solid Dispersions
Favorite
3:30 PM – 4:30 PM
ET
(T1530-11-71) Development of Inhalable Inclusion Complexes of Poorly Water Soluble Crizotinib for Treatment of Non-small Cell Lung Cancer
Favorite
3:30 PM – 4:30 PM
ET
(T1530-11-72) Evaluation of Supported-Liquid Extraction Technique and Matrix Effect in LCMS-MS Method Development of a Model Hydrophobic Drug
Favorite
3:30 PM – 4:30 PM
ET
(T1530-11-73) Investigating the Relationship between Microstructural Properties and In Vitro Release Characteristics of PLGA Microspheres
Favorite
3:30 PM – 4:30 PM
ET
(T1530-11-74) Optimizing the HME Process for Precise Manufacturing of Subcutaneous Drug Delivery Implants: Key Considerations for Quality and Efficiency
Favorite
3:30 PM – 4:30 PM
ET
(T1530-11-75) Suitable Powder Characteristics of ASDs for Direct Compression Obtained via Spray Drying
Favorite
3:30 PM – 4:30 PM
ET
(T1530-11-76) Solubility Enhancement via Amorphous Solid Dispersions: Extended Functionality by Applying a Versatile Polyvinyl Alcohol Platform for Hot Melt Extrusion
Favorite
3:30 PM – 4:30 PM
ET
(T1530-12-78) Preclinical Evaluation of Brinzolamide Ophthalmic Suspensions with Variations in Critical Quality Attributes and Considerations for Pharmacokinetic/Pharmacodynamic Study Designs
Favorite
3:30 PM – 4:30 PM
ET
(T1530-12-80) Elucidating the Mechanisms Underlying Enhanced Absorption in Rapidly Dissolving Amorphous Solid Dispersions
Favorite
3:30 PM – 4:30 PM
ET
(T1530-12-81) Evaluating the Impact of Excipient Selection on Nitrosamine Formation in Drug Products
Favorite
3:30 PM – 4:30 PM
ET
(T1530-12-82) Well Characterized Lipid Nanoparticle Library Accelerates Development of Next Generation Genomic Medicines
Favorite
3:30 PM – 4:30 PM
ET
(T1530-12-83) Development of a Novel Lipid Nanoparticle Based Immunochemotherapy against Brain Cancer
Favorite
3:30 PM – 4:30 PM
ET
(T1530-03-19) Utilization of Polymeric Micelles to Enhance Anticancer Activity through Combined Therapy with Luteolin and Doxorubicin
Favorite
3:30 PM – 4:30 PM
ET
(T1530-12-79) Dissolution Technology Using HPMCAS Solid Dispersion Targeting the Upper Small Intestine
Favorite
Back to Top
